HomeCompareHTBI vs JNJ

HTBI vs JNJ: Dividend Comparison 2026

HTBI yields 1.31% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HTBI wins by $75.1K in total portfolio value
10 years
HTBI
HTBI
● Live price
1.31%
Share price
$36.55
Annual div
$0.48
5Y div CAGR
58.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$105.3K
Annual income
$41,554.79
Full HTBI calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — HTBI vs JNJ

📍 HTBI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTBIJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTBI + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTBI pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTBI
Annual income on $10K today (after 15% tax)
$111.63/yr
After 10yr DRIP, annual income (after tax)
$35,321.57/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, HTBI beats the other by $31,335.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTBI + JNJ for your $10,000?

HTBI: 50%JNJ: 50%
100% JNJ50/50100% HTBI
Portfolio after 10yr
$67.8K
Annual income
$23,122.10/yr
Blended yield
34.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HTBI
Analyst Ratings
3
Buy
4
Hold
Consensus: Hold
Price Target
$42.00
+14.9% upside vs current
Range: $42.00 — $42.00
Altman Z
0.3
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTBI buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTBIJNJ
Forward yield1.31%2.13%
Annual dividend / share$0.48$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR58.1%28%
Portfolio after 10y$105.3K$30.3K
Annual income after 10y$41,554.79$4,689.40
Total dividends collected$79.5K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$42.00$228.73

Year-by-year: HTBI vs JNJ ($10,000, DRIP)

YearHTBI PortfolioHTBI Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,908$207.63$10,592$272.30+$316.00HTBI
2$12,006$334.63$11,289$357.73+$717.00HTBI
3$13,390$544.22$12,123$472.89+$1.3KHTBI
4$15,225$896.86$13,141$629.86+$2.1KHTBI
5$17,797$1,506.69$14,408$846.81+$3.4KHTBI
6$21,645$2,602.40$16,021$1,151.60+$5.6KHTBI
7$27,837$4,676.66$18,122$1,588.22+$9.7KHTBI
8$38,672$8,886.80$20,930$2,228.20+$17.7KHTBI
9$59,621$18,241.97$24,792$3,191.91+$34.8KHTBI
10$105,350$41,554.79$30,274$4,689.40+$75.1KHTBI

HTBI vs JNJ: Complete Analysis 2026

HTBIStock

HomeTrust Bancshares, Inc. operates as the bank holding company for HomeTrust Bank that provides a range of retail and commercial banking products and services. Its deposit products include savings, money market, and demand accounts, as well as certificates of deposit for individuals, businesses, and nonprofit organizations. The company's loan portfolio comprises retail consumer loans, such as one-to-four-family real estate lending, home equity lines of credit, construction and land/lots, indirect auto finance, and consumer lending; and commercial loans that include commercial real estate, construction and development, and commercial and industrial loans. It also provides small business administration loans, equipment finance leases, indirect automobile loans, and municipal leases; and cash management and online/mobile banking services. As of June 30, 2021, the company operated 41 offices in North Carolina, Upstate South Carolina, East Tennessee, and Southwest Virginia. HomeTrust Bancshares, Inc. was founded in 1926 and is headquartered in Asheville, North Carolina.

Full HTBI Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this HTBI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTBI vs SCHDHTBI vs JEPIHTBI vs OHTBI vs KOHTBI vs MAINHTBI vs ABBVHTBI vs MRKHTBI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.